Because the effects of age, menopausal status, weight and body mass index (BMI) on ovarian detectability by transvaginal ultrasound (TVS) have not been established, we determined their contributions to TVS visualization of the ovaries. A total of 29,877 women that had both ovaries visualized on their first exam were followed over 202,639 prospective TVS exams. All images were reviewed by a physician. While visualization of both ovaries decreased with age, one or both ovaries could be visualized in two of every three women over 80 years of age. Around 93% of pre-menopausal women and ~69% of post-menopausal women had both ovaries visualized. Both ovaries were visualized in ~72% of women weighing over 300 lbs. and in ~70% of women with a BMI o...
Objective: The purposes of this study were to verify whether ovarian volume differs according to chr...
The purpose of this study was to assess the accuracy of parametric analysis of transvaginal contrast...
Women that are positive for an ovarian abnormality in a clinical setting can have either a malignanc...
Because the effects of age, menopausal status, weight and body mass index (BMI) on ovarian detectabi...
Because the effects of age, menopausal status, weight and body mass index (BMI) on ovarian detectabi...
Objective: Some ovarian malignancies may originate in the fallopian tube. The feasibility of ultraso...
Objective: Transvaginal sonography (TVS) is core to any ovarian cancer screening strategy. General-p...
Transvaginal ultrasonography (TVS) is an integral part of all major ovarian cancer screening trials....
OBJECTIVE: In UKCTOCS self-reported visualization rates(srVR) at annual TVS scan was a key quality c...
OBJECTIVE: In the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS), self-reported visual...
OBJECTIVE: We have previously reported on the point prevalence of ovarian lesions detected by transv...
Objective: There are currently no programs to assess ovarian health in postmenopausal women. The aim...
Cancer of the ovary is the second most common gynaecological malignancy and is the 5th leading cause...
Background: Ovarian cancer is often diagnosed in advanced stages due to the absence of specific symp...
The authors evaluated ovarian volumes by transvaginal ultrasonography at different periods after men...
Objective: The purposes of this study were to verify whether ovarian volume differs according to chr...
The purpose of this study was to assess the accuracy of parametric analysis of transvaginal contrast...
Women that are positive for an ovarian abnormality in a clinical setting can have either a malignanc...
Because the effects of age, menopausal status, weight and body mass index (BMI) on ovarian detectabi...
Because the effects of age, menopausal status, weight and body mass index (BMI) on ovarian detectabi...
Objective: Some ovarian malignancies may originate in the fallopian tube. The feasibility of ultraso...
Objective: Transvaginal sonography (TVS) is core to any ovarian cancer screening strategy. General-p...
Transvaginal ultrasonography (TVS) is an integral part of all major ovarian cancer screening trials....
OBJECTIVE: In UKCTOCS self-reported visualization rates(srVR) at annual TVS scan was a key quality c...
OBJECTIVE: In the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS), self-reported visual...
OBJECTIVE: We have previously reported on the point prevalence of ovarian lesions detected by transv...
Objective: There are currently no programs to assess ovarian health in postmenopausal women. The aim...
Cancer of the ovary is the second most common gynaecological malignancy and is the 5th leading cause...
Background: Ovarian cancer is often diagnosed in advanced stages due to the absence of specific symp...
The authors evaluated ovarian volumes by transvaginal ultrasonography at different periods after men...
Objective: The purposes of this study were to verify whether ovarian volume differs according to chr...
The purpose of this study was to assess the accuracy of parametric analysis of transvaginal contrast...
Women that are positive for an ovarian abnormality in a clinical setting can have either a malignanc...